Month: December 2025
Court Finds “Optimal” and “Best” Patent Claims Too Vague for Enforcement
December 2, 2025
Akamai Techs., Inc. v. Mediapointe, Inc. Authored by: Jeremy J. Gustrowsky A recent decision highlights the importance of clear and objective language in patent claims, especially when using terms of degree like “optimal” or “best.” In a dispute between Akamai…
Read MorePatent Office Can Continue Reexams Even After IPRs and Patent Expiration, Court Says
December 2, 2025
In re Gesture Tech. Partners, LLC Authored by: Jeremy J. Gustrowsky A recent decision has clarified how patent challenges can proceed even after multiple rounds of review and the expiration of the patent itself. Gesture Technology Partners, LLC found itself…
Read MorePatent Invalidated: Written Description and Enablement Requirements Sink High-Profile Cancer Drug Dispute
December 2, 2025
Seagen Inc. v. Daiichi Sankyo Co., Ltd. Authored by: Jeremy J. Gustrowsky A recent decision from the Federal Circuit has brought clarity to the requirements for written description and enablement in patent law, with significant implications for pharmaceutical and biotech…
Read More